CDC - Vaccinations

Monthly Cumulative Number and Percent of Adults 60 Years and Older Who Received at least one RSV Vaccination Doses by Jurisdiction

• Estimated Respiratory Syncytial Virus (RSV) vaccination coverage for adults is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group.

• Starting in July 2023, the CDC recommended the RSV vaccine to protect against serious illness from RSV. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)

Tags: rsv vaccination, iis, immunization information system

Last updated: 2024-02-12 14:12:18+00:00

Related Datasets

Monthly Cumulative Number And Percent Of Adults 75 Years And Older Who Received 1+ RSV Vaccination Doses By Jurisdiction, United States

@cdc
Weekly Cumulative Percentage Of Adults 60 Years And Older Vaccinated With Respiratory Syncytial Virus (RSV) Vaccine By Jurisdiction

@cdc
Monthly Cumulative Number And Percent Of Children <20 Months Who Received Nirsevimab By Age Group And Jurisdiction, United States

@cdc
Weekly Differences In Cumulative RSV Vaccination Coverage Among Adults 75 And Older And 60–74 Years With High-Risk Conditions Ever Vaccinated With RSV Vaccine, Overall, By Selected Demographics

@cdc
Weekly Cumulative RSV Vaccination Coverage And Intent, Overall, By Selected Demographics And Jurisdiction, Among Adults 75 And Older And 60-74 Years With High-Risk Conditions Ever Vaccinated, United States

@cdc
Weekly Differences In Cumulative Respiratory Syncytial Virus (RSV) Vaccination Coverage And Comparison, Overall, By Jurisdiction, Among Adults 75 Years And Older And Adults 50-74 Years With High-Risk Conditions

@cdc

Monthly Cumulative Number And Percent Of Adults 75 Years And Older Who Received 1+ RSV Vaccination Doses By Jurisdiction, United States

Weekly Cumulative Percentage Of Adults 60 Years And Older Vaccinated With Respiratory Syncytial Virus (RSV) Vaccine By Jurisdiction

Monthly Cumulative Number And Percent Of Children <20 Months Who Received Nirsevimab By Age Group And Jurisdiction, United States

Weekly Differences In Cumulative RSV Vaccination Coverage Among Adults 75 And Older And 60–74 Years With High-Risk Conditions Ever Vaccinated With RSV Vaccine, Overall, By Selected Demographics

Weekly Cumulative RSV Vaccination Coverage And Intent, Overall, By Selected Demographics And Jurisdiction, Among Adults 75 And Older And 60-74 Years With High-Risk Conditions Ever Vaccinated, United States

Weekly Differences In Cumulative Respiratory Syncytial Virus (RSV) Vaccination Coverage And Comparison, Overall, By Jurisdiction, Among Adults 75 Years And Older And Adults 50-74 Years With High-Risk Conditions